CompuGroup Medical SE & Co. KGaA (CMPUY.PK) announced on Wednesday that CVC Capital Partners has surpassed the 17% minimum acceptance condition for its voluntary public tender offer.
As of January 22nd, the offer has been accepted for 3.85% of CompuGroup's share capital and voting rights. Additionally, CVC has directly acquired or holds indirectly, through instruments they control, an extra 13.62% through external share purchases.
The tender offer, set at EUR 22 per share, presents a 51.2% premium over the three-month average price prior to the offer announcement and a 33.5% premium compared to the closing price on December 6, 2024. Shareholders have until January 23rd to tender their shares.
Those opting not to participate in the tender may encounter risks linked to holding shares that are both illiquid and unlisted. CVC has indicated that the offer price will remain unchanged as part of the planned delisting.
The transaction, anticipated to conclude in the second quarter of 2025, is designed to support CompuGroup Medical's long-term growth and innovation objectives, while strengthening its standing in the e-health sector.
The founding Gotthardt family, which holds 50.1% of the shares, will maintain majority ownership, and there will be no domination or profit-transfer agreements for two years following the closure of the transaction.
